|
For more information please contact:
Kevin McGrath
212.245.4577
kevin@cameronassoc.com |
QuickLinks:
Press Releases »
Client Website »
Stock Quote »
Client Calendar » |
|
November 12, 2008: SCOLR Pharma, Inc. to Attend American Association of Pharmaceutical Scientists - AAPS - Annual Meeting and Exposition
- download word.doc (40 Kb) »
|
November 7, 2008: SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
- download word.doc (40 Kb) »
|
November 6, 2008: SCOLR Pharma, Inc. Announces Positive Top-Line Results From Pivotal Clinical Trial Evaluating Efficacy of Extended-Release Ibuprofen
- download word.doc (40 Kb) »
|
October 9, 2008: SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
- download word.doc (40 Kb) »
|
September 26, 2008: SCOLR Pharma's ANDA for 12-hour CDT-based Pseudoephedrine Accepted for Review by U.S. FDA
- download word.doc (40 Kb) »
|
September 24, 2008: SCOLR Pharma, Inc. Receives $3.1 Million Lease Termination Payment
- download word.doc (40 Kb) »
|
August 7, 2008: SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
- download word.doc (40 Kb) »
|
August 6, 2008: SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation
- download word.doc (40 Kb) »
|
July 29, 2008: SCOLR Pharma, Inc. Schedules Second Quarter 2008 Financial Results Conference Call for August 7, 2008 at 11:30 A.M. Eastern
- download word.doc (40 Kb) »
|
July 1, 2008: SCOLR Pharma, Inc. Advances Extended-Release Ibuprofen with Initiation of Clinical Study
- download word.doc (40 Kb) »
|
May 2, 2008: SCOLR Pharma, Inc. Reports First Quarter 2008 Financial Results
- download word.doc (40 Kb) »
|
May 1, 2008: SCOLR Pharma, Inc. Enters into Lease Buyout Agreement
- download word.doc (40 Kb) »
|
April 30, 2008: SCOLR Pharma, Inc. Announces Positive Progress for Lead Product
- download word.doc (40 Kb) »
|
April 25, 2008: SCOLR Pharma, Inc. Schedules First Quarter 2008 Financial Results Conference Call for May 2, 2008 at 11:30 A.M. Eastern
- download word.doc (40 Kb) »
|
March 11, 2008: SCOLR Pharma, Inc. Reports Year End 2007 Financial Results
- download word.doc (40 Kb) »
|
February 14, 2008: SCOLR Pharma, Inc. to Present at the Roth Capital Partners Conference
- download word.doc (40 Kb) »
|
December 5, 2007: SCOLR Pharma, Inc. Announces Extension of Research Agreement with Consumer Products Company to Co-Develop Novel Application of its CDT® Delivery Platform
- download word.doc (40 Kb) »
|
November 29, 2007: SCOLR Pharma, Inc. Announces Pricing of Registered Direct Offering
- download word.doc (40 Kb) »
|
November 9, 2007: SCOLR Pharma, Inc. to Attend American Association of Pharmaceutical Scientists - AAPS - Annual Meeting and Exposition
- download word.doc (40 Kb) »
|
November 1, 2007: SCOLR Pharma, Inc. Initiates Pivotal Trials for 12-hour Ibuprofen
- download word.doc (40 Kb) »
|
October 30, 2007: SCOLR Pharma, Inc. Reports Third Quarter 2007 Financial Results
- download word.doc (40 Kb) »
|
October 24, 2007: SCOLR Pharma, Inc. Schedules Third Quarter 2007 Financial Results Conference Call for October 30, 2007, at 11:30 A.M. Eastern
- download word.doc (40 Kb) »
|
October 23, 2007: SCOLR Pharma, Inc. and Dr. Reddy's Laboratories Enter into Collaboration and License Agreement
- download word.doc (40 Kb) »
|
October 8, 2007: SCOLR Pharma, Inc. Announces the Addition of Jeff Reich, M.D. and Greg Weaver to its Board of Directors
- download word.doc (40 Kb) »
|
August 29, 2007: SCOLR Pharma, Inc. to Present at the Roth Capital Partners 2007 New York Conference
- download word.doc (40 Kb) »
|
August 13, 2007: SCOLR Pharma, Inc. Announces New Board Member
- download word.doc (40 Kb) »
|
August 7, 2007: SCOLR Pharma, Inc. Reports Second Quarter 2007 Financial Results
- download word.doc (40 Kb) »
|
June 29, 2007: SCOLR Pharma, Inc. Receives Notice from the American Stock Exchange Regarding Composition of its Board
- download word.doc (40 Kb) »
|
June 18, 2007: SCOLR Pharma, Inc. Issued Fifth Drug Delivery Patent for CDT® Drug Delivery Platform
- download word.doc (40 Kb) »
|
June 14, 2007: SCOLR Pharma, Inc. Announces New Product Launch with Alliance Partner
- download word.doc (40 Kb) »
|
May 21, 2007: SCOLR Pharma, Inc. to Host Annual Stockholders Meeting
- download word.doc (40 Kb) »
|
May 8, 2007: SCOLR Pharma, Inc. Reports First Quarter 2007 Financial Results
- download word.doc (40 Kb) »
|
May 4, 2007: SCOLR Pharma, Inc. Schedules First Quarter 2007 Financial Results Conference Call for May 8, 2007 at 11:30 A.M. Eastern
- download word.doc (40 Kb) »
|
April 30, 2007: SCOLR Pharma, Inc. to Present at the Taglich Brothers 4th Annual Small Cap Equity Conference
- download word.doc (40 Kb) »
|
April 17, 2007: SCOLR Pharma Announces Positive Ibuprofen Study Results and Status of Commercialization Program
- download word.doc (40 Kb) »
|
April 9, 2007: SCOLR Pharma, Inc. Starts CDT®-Fenofibrate Testing
- download word.doc (40 Kb) »
|
March 15, 2007: SCOLR Pharma Says Wyeth Will Terminate Ibuprofen License; SCOLR Will Continue Development of 12-Hour Ibuprofen
- download word.doc (40 Kb) »
|
March 12, 2007: SCOLR Pharma, Inc. Reports Year-end 2006 Financial Results
- download word.doc (40 Kb) »
|
March 9, 2007: SCOLR Pharma Announces Research Collaboration with BioCryst Pharmaceuticals
- download word.doc (40 Kb) »
|
March 1, 2007: SCOLR Announces Completion of 12 hour CDT-Pseudoephedrine ANDA Registration Batches, New Drug Development Target
- download word.doc (40 Kb) »
|
February 14, 2007: SCOLR Pharma, Inc. to Present at the Roth Capital Partners Conference
- download word.doc (40 Kb) »
|
February 6, 2007: SCOLR Pharma Announces Positive Results from Its Second 24 hour CDT-Ondansetron Trial
- download word.doc (40 Kb) »
|
February 5, 2007: SCOLR PHARMA TO PRESENT AT THE AMERICAN STOCK EXCHANGE'S FIRST ANNUAL HEALTHCARE INVESTOR CONFERENCE
- download word.doc (40 Kb) » |
January 30, 2007: SCOLR Pharma Announces Receipt of Milestone Payment from Wyeth Consumer Healthcare
- download word.doc (40 Kb) » |
November 14, 2006: SCOLR Pharma Partner Introduces Three New Products Based on SCOLR Technology
- download word.doc (40 Kb) »
|
November 6, 2006: SCOLR Pharma, Inc. Reports Third Quarter 2006
- download word.doc (40 Kb) »
|
October 25, 2006: SCOLR Reports Promising Results from Second CDT®-Raloxifene Trial
- download word.doc (40 Kb) » |
October 24, 2006: SCOLR Commences CDT®-Ondansetron and Phenylephrine Testing
- download word.doc (40 Kb) » |
October 20, 2006: SCOLR Pharma, Inc. to Attend American Association of Pharmaceutical Scientists - AAPS - Annual Meeting and Exposition
- download word.doc (40 Kb) »
|
September 26, 2006: SCOLR Pharma Announces Achievement of Milestone With Wyeth Consumer Healthcare
- download word.doc (40 Kb) » |
September 25, 2006: SCOLR Pharma, Inc. to Present at the UBS Global Life Sciences Conference on September 27, 2006
- download word.doc (40 Kb) » |
September 22, 2006: SCOLR Pharma Enters Research Collaboration to Co-develop Novel Flu Application
- download word.doc (40 Kb) »
|
September 14, 2006: SCOLR Pharma, Inc. Engaged by Leading Consumer Products Company to Co-Develop Novel Application of its CDT® Delivery Platform
- download word.doc (40 Kb) »
|
August 31, 2006: SCOLR Pharma, Inc. to Present at the Roth Capital Partners 2006 New York Conference
- download word.doc (40 Kb) »
|
August 7, 2006: SCOLR Pharma, Inc. Reports Second Quarter 2006 Financial Results
- download word.doc (40 Kb) »
|
June 13, 2006: Results of the Annual Meeting of Stockholders of SCOLR Pharma, Inc. held on June 8, 2006
- download word.doc (40 Kb) » |
June 5, 2006: SCOLR Pharma's Strategic Alliance's Lead Product Introduction Gains Traction
- download word.doc (40 Kb) » |
May 9, 2006: SCOLR Pharma First Quarter 2006 Financial Results
- download word.doc (40 Kb) » |
April 19, 2006: SCOLR Pharma to Present at the at the UBS Global Specialty Pharmaceuticals Conference on April 24, 2006
- download word.doc (40 Kb) » |
April 18, 2006: SCOLR Pharma, Inc. to Raise $11.8 Million in Offering of Common Stock
- download word.doc (40 Kb) » |
March 23, 2006: SCOLR Pharma Reports Results for 2005
- download word.doc (40 Kb) » |
March 17, 2006: SCOLR Pharma Extends Form 10-K Filing; Company Expects to File Form 10-K Within Fifteen Days
- download word.doc (40 Kb) » |
March 13, 2006: SCOLR Pharma to Present at the Academy of Pharmaceutical Science and Technology, Japan
- download word.doc (40 Kb) » |
February 28, 2006: SCOLR Pharma Announces First Shipment from Its Strategic Alliance
- download word.doc (40 Kb) » |
February 16, 2006: SCOLR Pharma Reports Positive Ondansetron Clinical Results, New Drug Development Targets, and Revised Development Priorities
- download word.doc (40 Kb) » |
December 22, 2005: SCOLR Pharma Announces Worldwide Licensing Agreement with Wyeth Consumer Healthcare
- download word.doc (40 Kb) » |
November 16, 2005: SCOLR Pharma Retains Cameron Associates as Investor Relations Advisor
- download word.doc (40 Kb) » |